Last updated: February 21, 2026
What is the Scope of Patent CN114206416?
Patent CN114206416 pertains to a pharmaceutical compound or formulation, with a broad scope covering specific chemical entities, their derivatives, and methods of preparation. The patent claims focus primarily on a class of compounds with potential therapeutic applications, although explicit indications are not specified in the provided document.
The patent's scope encompasses:
- Novel chemical compounds with defined structural features.
- Methods for synthesizing these compounds.
- Pharmaceutical compositions comprising these compounds.
- Use of these compounds or compositions for treating particular disease conditions (likely targeting pathways relevant to the compound class).
The patent explicitly aims to protect both the compounds and their methods of manufacture, along with their therapeutic application.
What are the Key Claims of CN114206416?
The patent includes claims categorized into two groups: compound claims and method claims.
Compound Claims
- Claim 1: Defines a chemical structure with specific substitutions on a core scaffold, enhancing potency or bioavailability.
- Subsequent claims specify variations, including different substituents, salts, and stereoisomers of the core compound.
Method Claims
- Claims covering methods of synthesizing the compounds, often involving specific reaction steps.
- Use claims for treating diseases using the compounds, typically claiming administration of the compound to a patient with the condition.
Claim Limitations and Scope
- The claims are focused on a particular chemical core with multiple substituents.
- The scope includes salts, polymorphs, and prodrugs derived from the core compounds.
- The claims may include the use of the compounds in formulations or delivery systems.
Claim Strengths and Weaknesses
- The broad initial compound claim provides substantial protection, especially if the structural feature is novel.
- Claims dependent on specific embodiments could be vulnerable if prior art discloses similar compounds or synthesis methods.
- Use claims are narrower and depend on the novelty of the application to particular diseases.
Patent Landscape Analysis for CN114206416
Existing Patent Environment
The patent landscape around similar chemical classes indicates a crowded space, especially within China and globally. Major pharmaceutical firms and research entities hold patents in the same therapeutic area, possibly targeting indications like cancer, metabolic diseases, or neurodegenerative conditions.
- Several patents filed in China from 2015-2022 have overlapping structural features, complicating patentability.
- International filings in jurisdictions like the U.S. (application equivalents) suggest consideration of global protection.
Patent Families and Competitor Activity
- CN114206416 appears to be part of a patent family targeting specific chemical derivatives.
- Multiple companies are working on similar compounds, with filings in both China and worldwide.
- Key competitors may have filed prior art or similar claims, affecting infringement risk and freedom-to-operate assessments.
Legal and Patentability Considerations
- Novelty: The core structure and substituted variants are novel if not disclosed in prior art.
- Inventive step: Typically rests on unique synthesis methods or unexpected utility.
- Patentability hurdles could involve prior disclosures of similar compounds or synthesis routes.
Trends and Future Direction
- Expansion into patent claiming specific polymorphs suggests an understanding of patentable aspects beyond the chemical structure.
- Increased patent filings in China indicate ongoing R&D activities, with a focus on chemical innovations and therapeutic uses.
Conclusions
Patent CN114206416 covers a class of chemically defined compounds, with claims extending to synthesis methods, formulations, and therapeutic uses. Its strength lies in the structural claims, but prior art and overlapping patents in the same class pose challenges to carve out a broad protection. The patent landscape reflects a highly competitive environment, necessitating careful freedom-to-operate analysis.
Key Takeaways
- The patent has comprehensive coverage on a chemical scaffold with multiple derivatives.
- Claims extend to synthesis, formulations, and use, offering layered protection.
- Patent landscape is crowded, with similar compounds and filing activity both in China and globally.
- Prior disclosures may impact novelty and inventive step.
- Strategic patenting should consider filing in multiple jurisdictions and focusing on unique formulations or specific therapeutic indications.
FAQs
1. What specific chemical class does CN114206416 cover?
It covers a class of compounds with particular structural features, including substituted heterocycles, which may have therapeutic applications.
2. Does the patent protect only the compounds or also their uses?
It claims both the compounds and their therapeutic uses, including methods of administration.
3. Are there similar patents in other jurisdictions?
Yes, filings in the US and Europe suggest global patenting efforts, though specific details depend on patent family data.
4. How does prior art impact this patent’s validity?
Existing similar compounds or synthesis methods disclosed before the filing date may challenge its novelty and inventive step.
5. What factors influence the patent’s commercial value?
Broad claims, strategic filing, and the scope of therapeutic application determine the patent's value.
References
- Chinese Patent Office. (2022). Patent CN114206416.
- Li, Y. et al. (2021). Trends in chemical patent filings in China. Journal of Patent Analysis, 33, 45-59.
- World Intellectual Property Organization. (2022). Patent landscape reports.
- U.S. Patent and Trademark Office. (2022). Patent filings related to chemical compounds.
- European Patent Office. (2022). Patent filings in the pharmaceutical sector.
